10-Q · May 15, 2026
Edible Garden reported a 22.9% revenue growth in Q1 2026, reaching approximately $3.34 million, driven primarily by an increase in the cut herb segment. Nonetheless, the company reported a significant net loss of $3.67…
Earnings analysis · 10-Q
EDBL earnings analysis
Filed August 14, 2026 · Our reading of the company's report
The latest report
Edible Garden delivered $3.55 million of revenue, beating consensus by 5.0% and growing 12.8% year over year, but diluted EPS of $(18.79) missed expectations by approximately 60.6%. Lower SG&A of $3.1 million, down…
Read full summary
Edible Garden delivered $3.55 million of revenue, beating consensus by 5.0% and growing 12.8% year over year, but diluted EPS of $(18.79) missed expectations by approximately 60.6%. Lower SG&A of $3.1 million, down 21.5%, was not enough to offset the earnings shortfall. The filing adds a material Nasdaq delisting risk tied to a $5 million market-value requirement, with potential suspension after 30 consecutive business days of noncompliance and limited appeal jurisdiction through November 23, 2026.
Gross and operating margin
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported figures
- Earnings per share
- $-18.79
What stood out
-
Revenue beat and grew year over year
Revenue was $3.55 million, $0.169 million or 5.0% above the $3.381 million consensus estimate, and increased 12.8% year over year.
-
EPS materially missed consensus
Diluted EPS was $(18.79), missing the $(11.70) estimate by $(7.09), or approximately 60.6% below consensus.
-
Lower SG&A reduced operating pressure
SG&A declined 21.5% to $3.1 million, providing a cost offset despite the quarterly loss.
What to watch
-
Nasdaq market-value delisting risk
The company was not in compliance with Nasdaq's proposed $5 million market-value-of-listed-securities requirement as of June 30, 2026. If the requirement takes effect and the deficiency persists for 30 consecutive business days, the securities could be suspended and immediately delisted.
-
Limited window to cure listing issues
Nasdaq's listing appeal jurisdiction remains in place only through November 23, 2026; a new listing deficiency during that period could give the company just 7 calendar days to present a cure plan to the Panel.
Management's outlook
No quantitative forward revenue or EPS guidance was provided in the filing; outlook was deferred to the earnings release/call or otherwise not provided.
Earlier filings 4
10-K · April 30, 2026
Edible Garden AG reported a challenging fiscal year for 2025, highlighted by a revenue of $4 million, trailing behind prior expectations, and a significantly negative EPS of $(24.81) in Q4. The management noted severe…
10-K · March 31, 2026
Edible Garden describes a strategic pivot from primarily fresh produce to a vertically integrated ready‑to‑drink (RTD) and clean‑nutrition platform ("Farm‑to‑Formula®") by converting its Webster City, IA site into an…
10-Q · November 14, 2025
Edible Garden reported Q3 revenue of $2,817,000 (up $233,000 or ~9.0% vs. Q3 2024) but produced a larger net loss of $(4,045,000) versus $(2,063,000) in the prior-year quarter. Gross profit fell to $273,000 (gross…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.